Trial Profile
A phase I trial assessing pharmacokinetics of trastuzumab emtansine (T-DM1) in Japanese patients with HER2-positive metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Pharmacokinetics
- Sponsors Chugai Pharmaceutical; Roche
- 23 Sep 2015 New trial record